Reference health
Primary Hyperparathyroidism: An Overview
1 of 81 checkable references need attention · checked 2026-07-22
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
11 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
does not resolve to a known work10.1210/jc.86.2.485
The 80 checked references that resolve
resolves10.1359/JBMR.050910
Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993–2001: An Update on the Changing Epidemiology of the Disease
resolves10.1111/j.1365-2265.2007.02970.x
Asymptomatic hyperparathyroidism – need for multicentre studies
resolves10.1016/j.jpedsurg.2010.02.074
What is the optimal treatment for children with primary hyperparathyroidism?
resolves10.1007/BF00878365
Transient neonatal distal renal tubular acidosis with secondary hyperparathyroidism
resolves10.1136/adc.56.7.565
Transient neonatal hyperparathyroidism secondary to maternal pseudohypoparathyroidism.
resolves10.1172/JCI119137
In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.
resolves10.1055/s-2007-999521
Spectrum and Natural History of Congenital Hyperparathyroidism Secondary to Maternal Hypocalcemia
resolves10.1152/ajpendo.00315.2009
The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion
resolves10.1093/clinchem/37.2.162
Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism
resolves10.1093/clinchem/33.8.1364
Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.
resolves10.1359/jbmr.2001.16.4.605
Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1–84: Implications for Improvement of Accurate Assessment of Parathyroid Function
resolves10.1210/jc.2002-021266
Clinical Utility of an Immunoradiometric Assay for Parathyroid Hormone (1–84) in Primary Hyperparathyroidism
resolves10.1093/ndt/gfm849
Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study
resolves10.1373/clinchem.2005.065821
Comparison of 3 Third-Generation Assays for Bio-intact Parathyroid Hormone
resolves10.1016/0092-8674(93)90617-Y
Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism
resolves10.1210/jc.2008-1758
Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop
resolves10.1016/j.surg.2004.06.042
The coming of age of radiation-induced hyperparathyroidism: Evolving patterns of thyroid and parathyroid disease after head and neck irradiation
resolves10.1210/jc.83.8.2621
Mutation Analysis of the MEN1 Gene in Multiple Endocrine Neoplasia Type 1, Familial Acromegaly and Familial Isolated Hyperparathyroidism
resolves10.1038/ng1048
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome
resolves10.1210/jc.83.3.960
Absence of Germ-Line Mutations of the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene in Familial Pituitary Adenoma in Contrast to MEN1 in Japanese
resolves10.1056/NEJMoa031237
Somatic and Germ-Line Mutations of the<i>HRPT2</i>Gene in Sporadic Parathyroid Carcinoma
resolves10.1136/jmg.40.9.657
<i>HRPT2</i> mutations are associated with malignancy in sporadic parathyroid tumours
resolves10.1210/jc.2003-030675
Familial Isolated Hyperparathyroidism Is Rarely Caused by Germline Mutation in<i>HRPT2</i>, the Gene for the Hyperparathyroidism-Jaw Tumor Syndrome
resolves10.1007/s100380050048
Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma
resolves10.1210/jc.2007-1005
<i>RET</i>
Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center
resolves10.1136/jmg.32.12.934
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
resolves10.1073/pnas.0603877103
Germ-line mutations in p27
<i>
<sup>Kip1</sup>
</i>
cause a multiple endocrine neoplasia syndrome in rats and humans
resolves10.1136/jmg.26.5.289
A new syndrome of autosomal recessive nephropathy, deafness, and hyperparathyroidism.
resolves10.1073/pnas.0712361105
A translocation causing increased α-Klotho level results in hypophosphatemic rickets and hyperparathyroidism
resolves10.1126/science.7701349
A Constitutively Active Mutant PTH-PTHrP Receptor in Jansen-Type Metaphyseal Chondrodysplasia
resolves10.1172/JCI2918
Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
resolves10.1007/BF00572767
A new familial skeletal dysplasia with severely retarded ossification and abnormal modeling of bones especially of the epiphyses, the hands, and feet
resolves10.1016/j.ajhg.2008.11.006
PTHR1 Loss-of-Function Mutations in Familial, Nonsyndromic Primary Failure of Tooth Eruption
resolves10.1210/jc.2008-1757
The Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism Revisited
resolves10.1297/cpe.17.81
I-Cell Disease (Mucolipidosis II) Presenting as Neonatal Fractures: A Case for Continued Monitoring of Serum Parathyroid Hormone Levels
resolves10.1359/jbmr.1999.14.10.1700
Primary Hyperparathyroidism and the Risk of Fracture: A Population-Based Study
resolves10.1007/s00198-010-1226-1
Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis
resolves10.2214/AJR.06.0938
Parathyroid Imaging: Technique and Role in the Preoperative Evaluation of Primary Hyperparathyroidism
resolves10.1210/jc.2008-1763
Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop
resolves10.1093/ajcp/64.4.488
Primary Neonatal Hyperparathyroidism: Report of a Case and Review of the Literature
resolves10.1007/s00268-010-0569-2
Hyperparathyroidism in Pregnancy: Options for Localization and Surgical Therapy
resolves10.1007/BF01655086
Surgical treatment of ten cases of parathyroid carcinoma: Importance of an initial en bloc tumor resection
resolves10.1016/S0039-6060(98)70040-6
Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1
resolves10.1210/jc.85.1.165
Familial Isolated Hyperparathyroidism as a Variant of Multiple Endocrine Neoplasia Type 1 in a Large Danish Pedigree
resolves10.1016/j.jamcollsurg.2006.02.003
Consequences of Targeted Parathyroidectomy Guided by Localization Studies Without Intraoperative Parathyroid Hormone Monitoring
resolves10.1046/j.1445-2197.2002.02558.x
Minimal access thyroid surgery: Is it feasible, is it appropriate?
resolves10.1016/j.amjsurg.2005.01.029
Selective unilateral parathyroid exploration: an effective treatment for primary hyperparathyroidism
resolves10.1177/000313480707300404
Complications of Thyroidectomy and Parathyroidectomy in the Rural Community Hospital Setting
resolves10.1016/j.jamcollsurg.2009.01.048
Outpatient Minimally Invasive Parathyroidectomy Is Safe for Elderly Patients
resolves10.1111/j.1365-2265.2009.03540.x
Parathyroidectomy is safe and improves symptoms in elderly patients with primary hyperparathyroidism (PHPT)
resolves10.1016/S8756-3282(00)00291-X
Effects of two intermittent alendronate regimens in the prevention or treatment of postmenopausal osteoporosis
resolves10.1210/jc.2001-010385
Alendronate in the Treatment of Primary Hyperparathyroid-Related Osteoporosis: A 2-Year Study
resolves10.1016/j.jcms.2010.05.009
Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: Not just a sporadic coincidence – a multi-centre study
resolves10.7326/0003-4819-125-5-199609010-00002
Effect of Hormone Replacement Therapy on Bone Mineral Density in Postmenopausal Women with Mild Primary Hyperparathyroidism
resolves10.1210/jc.2004-0842
Cinacalcet Hydrochloride Maintains Long-Term Normocalcemia in Patients with Primary Hyperparathyroidism
resolves10.1210/jc.2002-021597
The Calcimimetic Cinacalcet Normalizes Serum Calcium in Subjects with Primary Hyperparathyroidism
resolves10.1056/NEJM198907273210402
Clonality of Parathyroid Tumors in Familial Multiple Endocrine Neoplasia Type 1
resolves10.1067/msy.2002.128695
Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism
resolves10.1007/BF01665301
Surgical treatment of primary hyperparathyroidism: An institutional perspective
resolves10.1007/BF02067367
Findings and long‐term results of parathyroid surgery in multiple endocrine neoplasia type 1
resolves10.1016/S0889-8529(18)30122-1
Management of Individual Tumor Syndromes: Medullary Thyroid Carcinoma and Hyperparathyroidism
resolves10.1016/j.amjsurg.2010.02.001
Determinants of Tc-99m sestamibi SPECT scan sensitivity in primary hyperparathyroidism
The 11 references without a DOI — listed, not checked
no DOI — not checked3
no DOI — not checked9
no DOI — not checked25
no DOI — not checked51
no DOI — not checked56
no DOI — not checked69
no DOI — not checked70
no DOI — not checked71
no DOI — not checked72
no DOI — not checkedRevision parathyroid surgery
no DOI — not checked93
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1155/2011/251410"><img src="https://citestamp.com/citestamped/10.1155/2011/251410/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1155/2011/251410)